🇺🇸 OSELTAMIVIR in United States

5,958 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 1,790 reports (30.04%)
  2. Drug Ineffective — 727 reports (12.2%)
  3. No Adverse Event — 585 reports (9.82%)
  4. Vomiting — 518 reports (8.69%)
  5. Nausea — 500 reports (8.39%)
  6. Headache — 416 reports (6.98%)
  7. Pneumonia — 387 reports (6.5%)
  8. Influenza — 359 reports (6.03%)
  9. Condition Aggravated — 342 reports (5.74%)
  10. Product Use In Unapproved Indication — 334 reports (5.61%)

Source database →

OSELTAMIVIR in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is OSELTAMIVIR approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for OSELTAMIVIR in United States?

Marketing authorisation holder not available in our data.